Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Y Locker

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer|September 15, 1985
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer CouncilM Haid, J D Khandekar, M Christ, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Drugs|July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic useR A Bender, L A Zwelling, J H Doroshow, et al.
Journal of the American College of Surgeons|July 10, 2001
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancerS F Sener, S Milos, J L Feldman, et al.
Journal of the National Cancer Institute|October 16, 1996
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markersD F Hayes, R C Bast, C E Desch, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer|September 15, 1985
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer CouncilM Haid, J D Khandekar, M Christ, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Drugs|July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic useR A Bender, L A Zwelling, J H Doroshow, et al.
Journal of the American College of Surgeons|July 10, 2001
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancerS F Sener, S Milos, J L Feldman, et al.
Journal of the National Cancer Institute|October 16, 1996
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markersD F Hayes, R C Bast, C E Desch, et al.
Pageof 3